Clinical trials
Active, not recruiting trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,085 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 3 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 16 |
| 2014 | 18 |
| 2015 | 23 |
| 2016 | 20 |
| 2017 | 45 |
| 2018 | 66 |
| 2019 | 90 |
| 2020 | 96 |
| 2021 | 155 |
| 2022 | 175 |
| 2023 | 148 |
| 2024 | 140 |
| 2025 | 64 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 1,085 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 52 |
| Novartis Pharmaceuticals | 42 |
| Janssen Research & Development, LLC | 38 |
| Erasmus Medical Center | 29 |
| Radboud University Medical Center | 28 |
| The Netherlands Cancer Institute | 24 |
| Hoffmann-La Roche | 23 |
| Merck Sharp & Dohme LLC | 23 |
| AbbVie | 22 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 20 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 61 |
| Neoplasms | 43 |
| Breast Neoplasms | 37 |
| Prostatic Neoplasms | 34 |
| Multiple Myeloma | 26 |
| Neoplasm Metastasis | 26 |
| Colorectal Neoplasms | 24 |
| Heart Failure | 20 |
| Cardiovascular Diseases | 19 |
| Colitis, Ulcerative | 17 |
Trials
Showing 1 to 25 of 1,085. Each trial links to its page on Pharma Observatory.
985 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.